Middle East & Africa Stem Cell Therapy Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2028 – Regional Analysis – by Type (Adult Stem Cell Therapy, Embryonic Stem Cell Therapy, Induced Pluripotent Stem Cell Therapy, and Other Stem Cell Therapy), Treatment (Allogeneic and Autologous), Application (Musculoskeletal, Dermatology, Cardiology, Drug Discovery & Development, and Other Applications), and End User (Hospitals & Specialty Clinics and Academic & Research Institutes)

No. of Pages: 125    |    Report Code: BMIRE00029078    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
Middle East & Africa Stem Cell Therapy Market
Free Sample Buy Now

1. Introduction

1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Hypothesis formulation:
  • 3.2.2 Macro-economic factor analysis:
  • 3.2.3 Developing base number:
  • 3.2.4 Data Triangulation:
  • 3.2.5 Country level data:

4. Middle East & Africa Stem Cell Therapy Market Landscape

4.1 Market Overview
4.2 Porter's Five Forces Analysis
  • 4.2.1 Bargaining Power of Suppliers
  • 4.2.2 Bargaining Power of Buyers
  • 4.2.3 Threat of New Entrants
  • 4.2.4 Competitive Rivalry
  • 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
  • 4.3.1 Raw Material Suppliers
  • 4.3.2 Manufacturers
  • 4.3.3 Distributors/Suppliers
  • 4.3.4 End Users

5. Middle East & Africa Stem Cell Therapy Market – Key Market Dynamics

5.1 Growth Drivers
  • 5.1.1 Increasing Research Activities Related to Stem Cell Therapy for Effective Disease Management to Favor the Market Growth
  • 5.1.2 Increasing Funding in Cancer Management To Enhance the Stem Cell Research Will Drive the Market Growth
5.2 Market Opportunities
  • 5.2.1 Use of Induced Pluripotent Stem Cells in Regenerative Medicines to Provide Lucrative Market Opportunity
5.3 Future Trends
  • 5.3.1 Research activities and product innovations are likely to remain key trends in the market.
5.4 Impact of Drivers and Restraints

6. Middle East & Africa Stem Cell Therapy Market Regional Analysis

6.1 Middle East & Africa Stem Cell Therapy Market Overview
6.2 Middle East & Africa Stem Cell Therapy Market Revenue 2020-2028 (US$ Million)
6.3 Middle East & Africa Stem Cell Therapy Market Forecast Analysis

7. Middle East & Africa Stem Cell Therapy Market Analysis – by Type

7.1 Adult Stem Cell Therapy
  • 7.1.1 Overview
  • 7.1.2 Adult Stem Cell Therapy: Middle East & Africa Stem Cell Therapy Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Embryonic Stem Cell Therapy
  • 7.2.1 Overview
  • 7.2.2 Embryonic Stem Cell Therapy: Middle East & Africa Stem Cell Therapy Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Induced Pluripotent Stem Cell Therapy
  • 7.3.1 Overview
  • 7.3.2 Induced Pluripotent Stem Cell Therapy: Middle East & Africa Stem Cell Therapy Market – Revenue and Forecast to 2031 (US$ Million)
7.4 Other Stem Cell Therapy
  • 7.4.1 Overview
  • 7.4.2 Other Stem Cell Therapy: Middle East & Africa Stem Cell Therapy Market – Revenue and Forecast to 2031 (US$ Million)

8. Middle East & Africa Stem Cell Therapy Market Analysis – by Treatment

8.1 Allogeneic
  • 8.1.1 Overview
  • 8.1.2 Allogeneic: Middle East & Africa Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
8.2 Autologous
  • 8.2.1 Overview
  • 8.2.2 Autologous: Middle East & Africa Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)

9. Middle East & Africa Stem Cell Therapy Market Analysis – by Application

9.1 Musculoskeletal
  • 9.1.1 Overview
  • 9.1.2 Autologous: Middle East & Africa Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
9.2 Dermatology
  • 9.2.1 Overview
  • 9.2.2 Autologous: Middle East & Africa Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
9.3 Cardiology
  • 9.3.1 Overview
  • 9.3.2 Autologous: Middle East & Africa Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Drug Discovery & Development
  • 9.4.1 Overview
  • 9.4.2 Autologous: Middle East & Africa Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Other Applications
  • 9.5.1 Overview
  • 9.5.2 Autologous: Middle East & Africa Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)

10. Middle East & Africa Stem Cell Therapy Market – Middle East and Africa Analysis

10.1 Middle East and Africa
  • 10.1.1 Middle East & Africa Stem Cell Therapy Market Breakdown, by Key Country, 2023 and 2028 (%)
  • 10.1.1.1 Middle East & Africa Stem Cell Therapy Market – Revenue and Forecast Analysis – by Country
  • 10.1.1.1 South Africa: Middle East & Africa Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.1.1 South Africa: Middle East & Africa Stem Cell Therapy Market Breakdown, by Type
    • 10.1.1.1.2 South Africa: Middle East & Africa Stem Cell Therapy Market Breakdown, by Treatment
    • 10.1.1.1.3 South Africa: Middle East & Africa Stem Cell Therapy Market Breakdown, by Application
  • 10.1.1.2 Saudi Arabia: Middle East & Africa Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.2.1 Saudi Arabia: Middle East & Africa Stem Cell Therapy Market Breakdown, by Type
    • 10.1.1.2.2 Saudi Arabia: Middle East & Africa Stem Cell Therapy Market Breakdown, by Treatment
    • 10.1.1.2.3 Saudi Arabia: Middle East & Africa Stem Cell Therapy Market Breakdown, by Application
  • 10.1.1.3 UAE: Middle East & Africa Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.3.1 UAE: Middle East & Africa Stem Cell Therapy Market Breakdown, by Type
    • 10.1.1.3.2 UAE: Middle East & Africa Stem Cell Therapy Market Breakdown, by Treatment
    • 10.1.1.3.3 UAE: Middle East & Africa Stem Cell Therapy Market Breakdown, by Application
  • 10.1.1.4 Rest of Middle East and Africa: Middle East & Africa Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.4.1 Rest of Middle East and Africa: Middle East & Africa Stem Cell Therapy Market Breakdown, by Type
    • 10.1.1.4.2 Rest of Middle East and Africa: Middle East & Africa Stem Cell Therapy Market Breakdown, by Treatment
    • 10.1.1.4.3 Rest of Middle East and Africa: Middle East & Africa Stem Cell Therapy Market Breakdown, by Application

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. Middle East & Africa Stem Cell Therapy Market Industry Landscape

12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 Lonza Group AG
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 Pluri Inc
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 Smith & Nephew Plc
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 TiGenix NV (Takeda Pharmaceutical Company Limited)
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments

14. Appendix

14.1 About Business Market Insights

The List of Companies - M Market

  1. Lonza Group AG
  2. Pluri Inc
  3. Smith & Nephew Plc
  4. TiGenix NV (Takeda Pharmaceutical Company Limited)
middle-east-and-africa-stem-cell-therapy-market